These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7930023)
1. The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies. Brun-Buisson C Intensive Care Med; 1994 May; 20(5):314-6. PubMed ID: 7930023 [No Abstract] [Full Text] [Related]
2. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis. Smith CR; Straube RC; Ziegler EJ Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120 [TBL] [Abstract][Full Text] [Related]
3. Clinical trials of immunotherapy for sepsis. Cunnion RE Crit Care Med; 1992 Jun; 20(6):721-3. PubMed ID: 1597020 [No Abstract] [Full Text] [Related]
6. Role of immunomodulator therapy in sepsis. Caplan ES Am J Surg; 1993 Feb; 165(2A Suppl):20S-25S. PubMed ID: 8438996 [TBL] [Abstract][Full Text] [Related]
7. Anti-endotoxin monoclonal antibodies--a second look. Wenzel RP N Engl J Med; 1992 Apr; 326(17):1151-3. PubMed ID: 1552918 [No Abstract] [Full Text] [Related]
8. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255 [TBL] [Abstract][Full Text] [Related]
9. Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans. Khazaeli MB; Wheeler R; Rogers K; Teng N; Ziegler E; Haynes A; Saleh MN; Hardin JM; Bolmer S; Cornett J J Biol Response Mod; 1990 Apr; 9(2):178-84. PubMed ID: 2341860 [TBL] [Abstract][Full Text] [Related]
10. [A cost-efficacy analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis]. Badía X; Segú L; García Alonso F; Rovira J Med Clin (Barc); 1993 Jan; 100(3):84-9. PubMed ID: 8426499 [TBL] [Abstract][Full Text] [Related]
11. HA-1A in septic patients with ARDS: results from the pivotal trial. Bigatello LM; Greene RE; Sprung CL; Panacek EA; Straube RC; Zimmerman JL; Maunder RJ; Lanken PN; Pile-Spellmann E; Stanek KS Intensive Care Med; 1994 May; 20(5):328-34. PubMed ID: 7930026 [TBL] [Abstract][Full Text] [Related]
12. Antibody to endotoxin in the treatment of gram-negative sepsis. Schentag JJ JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766 [No Abstract] [Full Text] [Related]
13. Antibody to endotoxin in the treatment of gram-negative sepsis. Spalter J JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764 [No Abstract] [Full Text] [Related]
14. Antibody to endotoxin in the treatment of gram-negative sepsis. McCabe WR JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763 [No Abstract] [Full Text] [Related]
15. Antibody to endotoxin in the treatment of gram-negative sepsis. van Deventer S JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765 [No Abstract] [Full Text] [Related]
16. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis. Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ Crit Care Med; 1992 Jun; 20(6):730-5. PubMed ID: 1597023 [TBL] [Abstract][Full Text] [Related]
17. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis]. van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630 [No Abstract] [Full Text] [Related]
18. Endotoxin-core antibodies: time for a reappraisal? Barclay GR Intensive Care Med; 1999 May; 25(5):427-9. PubMed ID: 10401932 [No Abstract] [Full Text] [Related]